For the Inventor, By the Inventor

Enter assignee name

Davis, CA, United States of America

Novo Nordisk Biotech, Inc.

USPTO Granted Patents = 62

Forward Citations = 458

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Randy M Berka (15 out of 63 patents)

Debbie Sue Yaver (10 out of 81 patents)

Joel R Cherry (9 out of 41 patents)

4. Claus Crone Fuglsang (8 out of 34 patents)

5. Jeffrey R Shuster (8 out of 23 patents)

6. Alan P Sloma (8 out of 25 patents)

7. Michael W Rey (7 out of 63 patents)

8. Feng Xu (6 out of 50 patents)

9. Torben Halkier (6 out of 45 patents)

10. Donna L Moyer (6 out of 17 patents)

11. Dorrit A Aaslyng (6 out of 31 patents)

12. Sheryl Ann Thompson (6 out of 9 patents)

13. John C Royer (5 out of 17 patents)

14. Susan L Elrod (5 out of 6 patents)

15. Helle Outtrup (4 out of 55 patents)

Core Competencies:

Galactose Oxidase

Phytase Activity

Aminolevulinic Acid

Uroporphyrinogen Decarboxylase

Filamentous Fungi

Choline Oxidase

Cellobiose Dehydrogenase

Protease Activity

Metalloprotease

Laccases

Fusarium Expression System

Thermophilic Fungal Expression

62 patents: Sort by Forward Citations

1. 6277612 - Polypeptides having galactose oxidase activity and nucleic acids encoding same (2001-08-21),

2. 6221644 - Polypeptides having phytase activity and nucleic acids encoding same (2001-04-24),

3. 6207433 - Polypeptides having aminolevulinic acid activity and nucleic acids encoding same (2001-03-27),

4. 6200795 - Polypeptides having uroporphyrinogen decarboxylase activity and nucleic acids encoding same (2001-03-13),

5. 6184028 - Polypeptides having pectin acetylesterase activity and nucleic acids encoding same (2001-02-06),

6. 6184026 - Morphological mutants of filamentous fungi (2001-02-06),

7. 6180366 - Methods for producing heterologous polypeptides in trichothecene-deficient (2001-01-30),

8. 6159688 - Methods of producing polynucleotide variants (2000-12-12),

9. 6146869 - Polypeptides having phospholipase B activity and nucleic acids encoding (2000-11-14),

10. 6146864 - Polypeptides having choline oxidase activity and nucleic acids encoding (2000-11-14),

11. 6129769 - Enzymatic methods for dyeing with reduced vat and sulfur dyes (2000-10-10),

12. 6100057 - Method for increasing hemoprotein production in filamentous fungi (2000-08-08),

13. 6090604 - Polypeptides having galactose oxidase activity and nucleic acids (2000-07-18),

14. 6066493 - Morphological mutants of filamentous fungi (2000-05-23),

15. 6063607 - Polypeptides having choline oxidase activity and nucleic acids encoding (2000-05-16),

Novo Nordisk Biotech, Inc. is a leading global pharmaceutical company specializing in diabetes care. With a mission to defeat diabetes, the company focuses on developing innovative and efficient ways to manage the disease through its biotech solutions. Novo Nordisk Biotech, Inc. is committed to improving the lives of millions of people living with diabetes by providing them with quality healthcare products and services.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

62 Patents

#4 in Davis, CA

#1,323 in California

#5,619 in US

#11,340 in the World

Davis, CA, United States of America

Novo Nordisk Biotech, Inc.

Forward Citations = 458

65 inventors:

Randy M Berka (15 out of 63 patents)

Debbie Sue Yaver (10 out of 81 patents)

Joel R Cherry (9 out of 41 patents)

4. Claus Crone Fuglsang (8 out of 34 patents)

5. Jeffrey R Shuster (8 out of 23 patents)

Please report any incorrect information to support@idiyas.com

Loading…